GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabpharm Ltd (HKSE:02181) » Definitions » PB Ratio

Mabpharm (HKSE:02181) PB Ratio : 6.39 (As of Jun. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mabpharm PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Mabpharm's share price is HK$0.345. Mabpharm's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.05. Hence, Mabpharm's PB Ratio of today is 6.39.

The historical rank and industry rank for Mabpharm's PB Ratio or its related term are showing as below:

HKSE:02181' s PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 4.5   Max: 9.26
Current: 6.9

During the past 7 years, Mabpharm's highest PB Ratio was 9.26. The lowest was 1.93. And the median was 4.50.

HKSE:02181's PB Ratio is ranked worse than
84.2% of 1310 companies
in the Biotechnology industry
Industry Median: 2.535 vs HKSE:02181: 6.90

During the past 12 months, Mabpharm's average Book Value Per Share Growth Rate was -50.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -40.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -11.90% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Mabpharm was 105.90% per year. The lowest was -40.20% per year. And the median was 5.05% per year.

Back to Basics: PB Ratio


Mabpharm PB Ratio Historical Data

The historical data trend for Mabpharm's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabpharm PB Ratio Chart

Mabpharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 4.05 4.15 5.59 3.99 8.52

Mabpharm Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.59 4.36 3.99 6.11 8.52

Competitive Comparison of Mabpharm's PB Ratio

For the Biotechnology subindustry, Mabpharm's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabpharm's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabpharm's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mabpharm's PB Ratio falls into.



Mabpharm PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Mabpharm's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.345/0.054
=6.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Mabpharm  (HKSE:02181) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Mabpharm PB Ratio Related Terms

Thank you for viewing the detailed overview of Mabpharm's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mabpharm (HKSE:02181) Business Description

Traded in Other Exchanges
N/A
Address
Lujia Road East, Koutai Road West, Block G79, China Medical City, Taizhou, CHN, 225300
Mabpharm Ltd is a biopharmaceutical company. The company is engaged in the research, development, and production of new drugs and biosimilars for cancers and autoimmune diseases. Its core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).
Executives
Guo Jianjun 2307 Founder of a discretionary trust who can infl
Asia Mabtech Limited
Asia Pacific Immunotech Venture Limited
Guo Family (ptc) Limited
Fortune-healthy Investment Limited
Link Best Capital Limited
Cdh Fund V, L.p.
Cdh Mabtech Limited
Cdh V Holdings Company Limited
China Diamond Holdings Company Limited
China Diamond Holdings V Limited

Mabpharm (HKSE:02181) Headlines

No Headlines